Detalles de la búsqueda
1.
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Cancer Med;
13(9): e7235, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716626
2.
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
BMC Cancer;
24(1): 446, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600471
3.
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
Health Technol Assess;
28(14): 1-101, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512064
4.
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023.
Gastric Cancer;
27(3): 401-425, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386238
5.
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.
Clin Cancer Res;
30(10): 2140-2159, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376926
6.
Updates on Systemic Therapy for Hepatocellular Carcinoma.
Am Soc Clin Oncol Educ Book;
44: e430028, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175973
7.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer;
27(2): 375-386, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281295
8.
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
J Pathol;
262(2): 226-239, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964706
9.
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial.
Clin Microbiol Infect;
30(1): 92-99, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37517522
10.
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital.
Clin Lymphoma Myeloma Leuk;
24(1): 48-54, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734988
11.
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.
Front Oncol;
13: 1258365, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38094609
12.
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
BMC Cancer;
23(1): 1056, 2023 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919668
13.
Pembrolizumab as a first-line treatment for advanced gastric cancer.
Lancet Oncol;
24(11): 1158-1159, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875145
14.
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
EClinicalMedicine;
60: 102015, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287870
15.
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study.
Lancet Oncol;
24(7): 744-756, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329891
16.
A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications.
Blood Cancer J;
13(1): 54, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072385
17.
Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre.
BMC Cancer;
23(1): 380, 2023 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101114
18.
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials.
Br J Cancer;
128(11): 2036-2043, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966233
19.
ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C).
BMC Cancer;
23(1): 257, 2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941575
20.
Is there still a place for radiotherapy in gastric cancer?
Curr Opin Pharmacol;
68: 102325, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610101